Form 10-QSB

                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                   Quarterly Report Under Section 13 or 15 (d)
                     of the Securities Exchange Act of 1934


For Quarter Ended:            February 28, 2006
                  -----------------------------------------------
Commission File Number:             0-11050
                       ------------------------------------------

                              Mammatech Corporation
               --------------------------------------------------
             (Exact name of registrant as specified in its charter)


           Florida                              59-2181303
--------------------------------------------------------------------------------
(State or other jurisdiction of           (I.R.S. Employer
incorporation or organization)             Identification Number)


930 N.W. 8th Avenue, Gainesville, Florida         32601
--------------------------------------------------------------------------------
(Address of principal executive offices)        (Zip Code)


                                 (352) 375-0607
               --------------------------------------------------
              (Registrant's telephone number, including area code)


Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by section 13 or 15 (d) of the Securities Exchange Act of 1934
during the preceding 12 months (or for such shorter period that the registrant
was required to file such reports), and (2) has been subject to such filing
requirements for the past ninety days. Yes [x] No [ ]

Indicate by a check mark whether the registrant is a shell company (as defined
in Rule 12b-2 of the Exchange Act)  Yes [  ]   No [ X ]

Indicate the number of shares outstanding of each of the issuer's classes of
common stock, as of the latest practicable date:

                Number of shares outstanding on February 28, 2006
                -------------------------------------------------

                            5,202,625 shares of which
                           310,426 are treasury shares

                              TITLE OF EACH CLASS
                              -------------------
                         Common stock $.0001 par value


<PAGE>

                              Mammatech Corporation

                                      INDEX

--------------------------------------------------------------------------------

PART I.

     FINANCIAL INFORMATION                                             PAGE NO.


     Item 1.  Financial Statements

     Balance Sheet at February 28, 2006......................................3

     Statements of Operations for Three Months and Six Months
     Ended February 28, 2005 and February 28, 2006...........................4

     Statements of Cash Flows for the Six Months
     Ended February 28, 2005 and February 28, 2006...........................5

     Notes to Financial Statements for the Six Months
     Ended February 28, 2006.................................................6

     Item 2.  Management's Discussion and Analysis of
     Financial Conditions and Results of Operations.........................7

     Item 3.  Controls and Procedures.......................................8


PART II.     OTHER INFORMATION


     Item 6.  Exhibits and Reports on Form 8-K..............................9

     SIGNATURES............................................................10

     EXHIBITS



                                        2
<PAGE>



                         Mammatech Corporation
                             Balance Sheet
                           February 28, 2006
                              (Unaudited)
                                 ASSETS
Current assets:
  Cash                                                              $   163,092
  Accounts receivable - trade                                            34,785
  Inventory                                                             106,594
                                                                    -----------
      Total current assets                                              304,471
                                                                    -----------

Property and equipment, at cost, net                                    173,684
                                                                    -----------

Available for sale securities                                           472,538
Patents, trademarks and other intangibles, net                            3,123
                                                                    -----------
                                                                        475,661

                                                                    $   953,816
                                                                    ===========
LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities:
  Accounts payable and accrued expenses                             $    34,823
  Accounts payable and accrued salaries - officers                      884,550
                                                                    -----------
      Total current liabilities                                         919,373
                                                                    -----------

Stockholders' equity:
 Common stock, $.0001 par value,
  200,000,000 shares authorized, 5,227,625
  shares issued and outstanding                                             523
 Additional paid-in capital                                           2,862,206
 Accumulated (deficit)                                               (2,681,996)
                                                                    -----------
                                                                        180,733
 Treasury stock, at cost, 310,425 shares                               (148,051)
                                                                    -----------
                                                                         32,682
Other comprehensive income:
 Unrealized gain on marketable securities                                 1,761
                                                                    -----------
                                                                         34,443

                                                                    $   953,816
                                                                    ===========


                 See accompanying notes to financial statements.


                                       3



<PAGE>


<TABLE>
<CAPTION>

                                                     Mammatech Corporation
                                            Statements of Comprehensive Operations
                                   Three Months and Six Months Ended February 28, 2005 and 2006
                                                         (Unaudited)


                                                                         Three Months                          Six Months
                                                                         ------------                          ----------
                                                                  2005                2006               2005                2006
                                                                  ----                ----               ----               ----

<S>                                                            <C>                <C>                <C>                <C>
Sales, net                                                     $    64,414        $    76,885        $   138,334        $   158,985
Cost of sales                                                       14,384             19,808             34,203             40,418
                                                               -----------        -----------        -----------        -----------
Gross profit                                                        50,030             57,077            104,131            118,567
                                                               -----------        -----------        -----------        -----------

Selling, general and administrative expenses                       110,688             95,663            222,131            188,856
                                                               -----------        -----------        -----------        -----------
(Loss) from operations                                             (60,658)           (38,586)          (118,000)           (70,289)
                                                               -----------        -----------        -----------        -----------

Other income and (expense):
  Gain on sale of investment securities                              4,338              1,636              6,739              1,636
  Interest and dividend income                                      11,101             14,877             18,868             21,194
                                                               -----------        -----------        -----------        -----------
                                                                    15,439             16,513             25,607             22,830
                                                               -----------        -----------        -----------        -----------

(Loss) before income taxes                                         (45,219)           (22,073)           (92,393)           (47,459)
Provision for income taxes                                            --                 --                 --                 --
                                                               -----------        -----------        -----------        -----------
Net (loss)                                                     $   (45,219)       $   (22,073)       $   (92,393)       $   (47,459)
                                                               ===========        ===========        ===========        ===========

Basic and fully diluted earnings per share:
 Net (loss)                                                    $     (0.01)       $     (0.00)       $     (0.02)       $     (0.01)
                                                               ===========        ===========        ===========        ===========
 Weighted average shares outstanding                             5,202,625          5,227,625          5,202,625          5,227,625
                                                               ===========        ===========        ===========        ===========

  Net (loss)                                                   $   (45,219)       $   (22,073)       $   (92,393)       $   (47,459)
   Unrealized gain from investments, net of
    income taxes                                                    (4,763)            11,831             38,652              4,192
                                                               -----------        -----------        -----------        -----------
  Comprehensive (loss)                                         $   (49,982)       $   (10,242)       $   (53,741)       $   (43,267)
                                                               ===========        ===========        ===========        ===========


                                                     See accompanying notes to financial statements.


                                                                          4
<PAGE>



                                              Mammatech Corporation
                                            Statements of Cash Flows
                                   Six Months Ended February 28, 2005 and 2006
                                                   (Unaudited)


                                                                     2005                   2006
                                                                     ----                   ----

Cash flows from operating activities:
  Net cash (used in) operating activities                          $ (81,987)             $ (18,358)
                                                                   ---------              ---------

Cash flows from investing activities:
   Purchase of available for sale securities                        (120,535)                (9,330)
   Proceeds from the sale of available for sale securities           201,577                112,420
   Acquisition of property and equipment                                --                   (1,398)
                                                                   ---------              ---------
Net cash provided by investing activities                             81,042                101,692
                                                                   ---------              ---------

Cash flows from financing activities:
Net cash provided by (used in) financing activities                     --                     --
                                                                   ---------              ---------

Increase (decrease) in cash                                             (945)                83,334

Cash and cash equivalents,
 beginning of period                                                 167,844                 79,758
                                                                   ---------              ---------
Cash and cash equivalents,
 end of period                                                     $ 166,899              $ 163,092
                                                                   =========              =========



                                   See accompanying notes to financial statements.

                                                      5
</TABLE>

<PAGE>


                              MAMMATECH CORPORATION
                          NOTES TO FINANCIAL STATEMENTS
                                FEBRUARY 28, 2006
                                   (UNAUDITED)

(1)      Basis Of Presentation

The accompanying unaudited financial statements have been prepared in accordance
with generally accepted accounting principles (GAAP) for interim financial
information and Item 310(b) of Regulation S-B. They do not include all of the
information and footnotes required by GAAP for complete financial statements. In
the opinion of management, all adjustments (consisting only of normal recurring
adjustments) considered necessary for a fair presentation have been included.

The results of operations for the periods presented are not necessarily
indicative of the results to be expected for the full year. For further
information, refer to the financial statements of the Company as of August 31,
2005, and for the two years then ended, including notes thereto included in the
Company's Form 10-KSB.

(2)      Earnings Per Share

The Company calculates net income (loss) per share as required by Statement of
Financial Accounting Standards (SFAS) 128, "Earnings per Share." Basic earnings
(loss) per share is calculated by dividing net income (loss) by the weighted
average number of common shares outstanding for the period. Diluted earnings
(loss) per share is calculated by dividing net income (loss) by the weighted
average number of common shares and dilutive common stock equivalents
outstanding. During periods when anti-dilutive commons stock equivalents are not
considered in the computation.

(3)      Inventory

Inventory is stated at the lower of cost, determined on a first in, first out
basis, or market value. Inventory consists principally of finished goods and
packaging materials.

(4)      Available For Sale Securities

Marketable securities consist of the following at February 28, 2006:

Mutual funds and equity securities with a fair market value of $472,538. The
cost basis of these securities is $470,777.

The gross realized gains on sales of available-for-sale securities were $1,636
during the six months ended February 28, 2006. The unrealized holding gains on
available-for-sale securities included in accumulated other comprehensive income
as a component of stockholders' equity increased by $4,192 during the six months
ended February 28, 2006, and totaled $1,761 at February 28, 2006.

During the six months ended February 28, 2006,, the Company increased its
investment in available for sale securities by $9,330 and realized net proceeds
from the sale of available for sale securities of $112,420.


                                       6
<PAGE>


MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITIONS AND
RESULTS OF OPERATION FOR MAMMATECH CORPORATION

The following discussion should be read in conjunction with the accompanying
financial statements and notes thereto included within this Quarterly Report on
Form 10-QSB. In addition to historical information, the information in this
discussion contains forward-looking statements within the meaning of Section 27A
of the Securities Act of 1933, as amended, and Section 21E of the Securities
Exchange Act of 1934, as amended. These forward-looking statements involve risks
and uncertainties, including statements regarding the Company's capital needs,
business strategy and expectations. Any statements contained herein that are not
statements of historical facts may be deemed to be forward-looking statements.
In some cases, you can identify forward-looking statements by terminology such
as "may", "will", "should", "expect", "plan", "Intend", "anticipate", "believe",
estimate", "predict", "potential" or "continue", the negative of such terms or
other comparable terminology. Actual events or results may differ materially. In
evaluating these statements, you should consider various factors described in
this Quarterly Report, including the risk factors accompanying this Quarterly
Report, and, from time to time, in other reports the Company files with the
Securities and Exchange Commission. These factors may cause the Company's actual
results to differ materially from any forward-looking statement. The Company
disclaims any obligation to publicly update these statements, or disclose any
difference between its actual results and those reflected in these statements.
The information constitutes forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995.


OVERVIEW

The results of the second quarter of Fiscal 2006 are mixed in comparison to both
the previous quarter and the second quarter of 2005. Net sales increased by 58%
over the same quarter 2005, but declined by 6.4% in comparison to the first
quarter 2006. Similarly, gross profit increased by 135% compared to the year ago
quarter but decreased by 7.2% compared to last quarter. Operating expense during
the current quarter increased by 2.6% over the prior quarter and but decreased
by 32.6% relative to the second quarter of 2005. The resulting net loss of
$22,073 compares with a net loss of $103,378 produced during the second quarter
of last year and is a 13% smaller loss than was sustained in the first quarter.

The six-month results show improvement over the same period of 2005. Sales
revenues increased by 14.9% while operating expense decreased by 15% compared to
the same period of the prior year. The net loss of $47,459 for the first half of
the year compares favorably with the net loss of $92,393 during the comparable
period of 2005.

As the data illustrate, the Company continues to experience a level of sales
over the past several quarters that appears to result from a combination of
economic factors arising in part from the fact that the country is at war.
Orders by military customers, normally a substantial portion of the Company's
business, were again virtually nonexistent in the second quarter. Similarly,
sales to other governmental agencies continue to be greatly diminished.

The Company trained eleven MammaCare Specialists during the quarter, compared
with five trained during the previous quarter. In addition, the Company trained
and certified eight individuals as MammaCare Clinical Breast Examiners and 19
MammaCare BSE instructors. All of the latter were trained in the German
MammaCare Training Center. The Clinical Breast Examiners were trained in the New
Mexico facility while the Specialists were trained in both the Florida and
Oregon Centers. Thus, the Company's strategy of broadening the geographic
availability of its advanced training is beginning to show results.

The Company has no immediate liquidity problems and continues to seek other
opportunities to expand its manufacturing and marketing activities.


                                       7
<PAGE>


Item 3.  Controls and Procedures

As of the end of the period covered by this report, the Corporation's Chief
Executive Officer and Chief Financial Officer evaluated the effectiveness of the
Corporation's disclosure controls and procedures. Based on the evaluation, the
Corporation's Chief Executive Officer and Chief Financial Officer concluded that
the Corporation's disclosure controls and procedures are effective as of the end
of the period covered by this report in that information required to be
disclosed in reports filed under the Securities Exchange Act of 1934, as
amended, has been recorded, processed, summarized and reported within the
current fiscal quarter. There were no changes in the Corporation's internal
control over financial reporting that occurred during the Corporation's most
recent fiscal quarter that have materially affected, or are reasonably likely to
materially affect, the Corporation's internal control over financial reporting.


                                        8
<PAGE>


PART II - OTHER INFORMATION

Item 1.  Legal Proceedings
                           None

Item 2.  Changes in securities
                           One to twenty reverse split

Item 3.  Default upon senior securities
                           None

Item 4.  Submissions of matters to a vote of securities holders
                           None

Item 5.  Other information
                           None

Item 6.  Exhibits and Reports on Form 8-K

   (a.)  Exhibits






                                        9
<PAGE>



                                   Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.

                                            MAMMATECH CORPORATION



DATE: April 19, 2006                        BY: /s/ Henry S. Pennypacker
                                            ----------------------------
                                            Henry S. Pennypacker, President
                                            and Director


                                            BY: /s/ Mary Sellers
                                            --------------------
                                            Mary Sellers, Treasurer and
                                            Chief Financial Officer


                                       10